Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Locally Advanced or Metastatic Hepato-Biliary Cancers
NCT00101036Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2004
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in hepatocellular carcinoma (HCC), biliary tract cancer (BTC), sponsored by National Cancer Institute. Started Nov 2004; status: completed.
02
Drugs
lapatinib
03
Conditions
hepatocellular carcinoma (HCC)biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00101036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101036.